Pharma-Bio Serv, Inc.
PBSV
$0.50
$0.012.04%
OTC PK
| 01/31/2026 | 10/31/2025 | 07/31/2025 | 04/30/2025 | 01/31/2025 | |
|---|---|---|---|---|---|
| Revenue | 8.82M | 9.00M | 9.18M | 9.64M | 9.60M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 8.82M | 9.00M | 9.18M | 9.64M | 9.60M |
| Cost of Revenue | 5.96M | 6.09M | 6.30M | 6.69M | 6.85M |
| Gross Profit | 2.86M | 2.91M | 2.89M | 2.95M | 2.75M |
| SG&A Expenses | 3.50M | 3.55M | 3.55M | 3.68M | 3.69M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 9.46M | 9.64M | 9.84M | 10.37M | 10.54M |
| Operating Income | -640.00K | -637.70K | -658.50K | -726.40K | -941.50K |
| Income Before Tax | -67.30K | -94.10K | -113.20K | -194.40K | -487.90K |
| Income Tax Expenses | 8.70K | 6.20K | -29.20K | -5.40K | 10.30K |
| Earnings from Continuing Operations | -0.08 | -0.10 | -0.08 | -0.19 | -0.50 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -76.10K | -100.50K | -84.30K | -189.20K | -498.40K |
| EBIT | -640.00K | -637.70K | -658.50K | -726.40K | -941.50K |
| EBITDA | -574.80K | -577.90K | -608.60K | -687.70K | -916.10K |
| EPS Basic | 0.00 | 0.00 | 0.00 | -0.01 | -0.02 |
| Normalized Basic EPS | 0.00 | 0.00 | 0.00 | -0.01 | -0.01 |
| EPS Diluted | 0.00 | 0.00 | 0.00 | -0.01 | -0.02 |
| Normalized Diluted EPS | 0.00 | 0.00 | 0.00 | -0.01 | -0.01 |
| Average Basic Shares Outstanding | 91.71M | 91.77M | 91.79M | 91.83M | 91.85M |
| Average Diluted Shares Outstanding | 91.74M | 91.79M | 91.81M | 91.84M | 91.86M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -2,260.05% | -1,711.34% | -2,040.21% | -909.04% | -345.55% |